APA

Terzolo M., Baudin A. E., Ardito A., Kroiss M., Leboulleux S., Daffara F., Perotti P., Feelders R. A., deVries J. H., Zaggia B., De Francia S., Volante M., Haak H. R., Allolio B., Al Ghuzlan A., Fassnacht M. & Berruti A. (20130930). Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. : European journal of endocrinology.

Chicago

Terzolo M, Baudin A E, Ardito A, Kroiss M, Leboulleux S, Daffara F, Perotti P, Feelders R A, deVries J H, Zaggia B, De Francia S, Volante M, Haak H R, Allolio B, Al Ghuzlan A, Fassnacht M and Berruti A. 20130930. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. : European journal of endocrinology.

Harvard

Terzolo M., Baudin A. E., Ardito A., Kroiss M., Leboulleux S., Daffara F., Perotti P., Feelders R. A., deVries J. H., Zaggia B., De Francia S., Volante M., Haak H. R., Allolio B., Al Ghuzlan A., Fassnacht M. and Berruti A. (20130930). Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. : European journal of endocrinology.

MLA

Terzolo M, Baudin A E, Ardito A, Kroiss M, Leboulleux S, Daffara F, Perotti P, Feelders R A, deVries J H, Zaggia B, De Francia S, Volante M, Haak H R, Allolio B, Al Ghuzlan A, Fassnacht M and Berruti A. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. : European journal of endocrinology. 20130930.